|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 912.9 DKK | -0.46% |
|
+3.36% | +30.77% |
| May. 16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
| May. 16 | Novo Nordisk Reports Fire Incident at Under-Construction Facility in Kalundborg, Denmark | MT |
By Dominic Chopping
Danish pharmaceutical giant Novo Nordisk raised full-year guidance to reflect better pricing in the U.S. and as global demand for its hit weight-loss and diabetes drugs continues to outstrip supply.
The company said Thursday that sales of its blockbuster Ozempic diabetes drug rose 42% on the year in the first quarter, while sales of obesity treatment Wegovy more than doubled.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
05-02-24 0208ET
| 1st Jan change | Capi. | |
|---|---|---|
| +30.77% | 595B | |
| +32.36% | 709B | |
| -1.60% | 367B | |
| +20.07% | 334B | |
| +6.04% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.27% | 171B | |
| +0.45% | 163B |
NOVO NORDISK A/S 
